Reducing errors in the management of hyperbilirubinaemia: validating a software application.

Objective: To verify the usefulness and reliability of a software tool we developed to help to apply the American Academy of Pediatrics (AAP) Guidelines 2004 on hyperbilirubinaemia according to the infant's age in hours and their clinical risk factors.

Design: Randomised, cross-over, controlled trial with 20 simulated clinical cases comparing the "manual" application of the guidelines with our software application.

Participants: Fifteen doctors (eight final-year residents and seven consultants) from two hospitals in Spain.